CAMBRIDGE, Mass., May 9, 2025 /PRNewswire/ -- MetaVia Inc. (Nasdaq: MTVA) ("MetaVia"), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced a private placement that MetaVia estimates will result in gross proceeds of approximately $10.0...
MetaVia Announces $10.0 Million Private Placement Priced At-The-Market under Nasdaq Rules
Seeking Alpha / 14 hours ago 2 Views
Comments